SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-15-230403
Filing Date
2015-06-22
Accepted
2015-06-22 16:01:34
Documents
7
Period of Report
2015-08-28

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d947085dpre14a.htm PRE 14A 330274
2 GRAPHIC g947085ltr_pg01a.jpg GRAPHIC 5275
3 GRAPHIC g947085ltr_pg01b.jpg GRAPHIC 5751
4 GRAPHIC g947085not_pg01a.jpg GRAPHIC 5275
5 GRAPHIC g947085not_pg01b.jpg GRAPHIC 5751
6 GRAPHIC g947085pc_pg01a.jpg GRAPHIC 1603
7 GRAPHIC g947085pc_pg01b.jpg GRAPHIC 1710
  Complete submission text file 0001193125-15-230403.txt   367458
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33004 | Film No.: 15944836
SIC: 2834 Pharmaceutical Preparations